You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 6, June 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cardiac Transplantation in a Patient With Muscular Dystrophy and Cardiomyopathy

Peter D. Donofrio, MD; Venkata R. Challa, MD; Barry T. Hackshaw, MD; Stephen A. Mills, MD; A. Robert Cordell, MD

Arch Neurol. 1989;46(6):705-707.


Abstract

• A 17-year-old boy with muscular dystrophy developed a cardiomyopathy. His brother died of a cardiomyopathy, and muscle enzyme levels were elevated in asymptomatic family members. Examination revealed cardiomegaly, hepatomegaly, proximal muscle atrophy and weakness, and calf hypertrophy. Skeletal muscle and endomyocardial biopsy specimens were consistent with Becker's muscular dystrophy. Because of intractable heart failure, orthotopic cardiac transplantation was performed. Two years after transplantation, the patient has returned to work and regained previous exercise tolerance. Heart transplantation can be an acceptable treatment of patients who have muscular dystrophy, with preserved ambulation and favorable life expectancy, and also life-threatening cardiomyopathy refractory to medical management.



Author Affiliations

From the Departments of Neurology (Dr Donofrio), Pathology (Dr Challa), Cardiology (Dr Hackshaw), and Surgery (Drs Mills and Cordell), Wake Forest University, The Bowman Gray School of Medicine, Winston-Salem, NC.


Footnotes

Accepted for publication Sept 15, 1988.

Presented in part at the 39th Annual Meeting of the American Academy of Neurology, New York, April 8, 1987.

Reprint requests to Department of Neurology, The Bowman Gray School of Medicine, 300 S Hawthorne Rd, Winston-Salem, NC 27103 (Dr Donofrio).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dilated Cardiomyopathy of Becker-Type Muscular Dystrophy with Exon 4 Deletion: A Case Report
Saotome et al.
ANGIOLOGY 2001;52:343-347.
ABSTRACT  

Cardiac Manifestations of Congenital Fiber-Type Disproportion Myopathy
Banwell et al.
J Child Neurol 1999;14:83-87.
ABSTRACT  

Myocardial Involvement Is Very Frequent Among Patients Affected With Subclinical Becker's Muscular Dystrophy
Melacini et al.
Circulation 1996;94:3168-3175.
ABSTRACT | FULL TEXT  

Current Concepts Review - Update on the Genetic Bases of Disorders with Orthopaedic Manifestations
DIETZ and MATHEWS
JBJS 1996;78:1583-98.
FULL TEXT  

Deficiency of a Dystrophin-Associated Glycoprotein (Adhalin) in a Patient with Muscular Dystrophy and Cardiomyopathy
Fadic et al.
NEJM 1996;334:362-366.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.